FB301: First-in-Human Study

We are testing a new medication called FB301 in healthy women to evaluate its safety and how it is processed in the body. This study aims to gather important information for future research.

Safety phase (I)Gynecology and Obstetrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
CRS Clinical Research Services Management GmbH
Clinic
Glienicke, Germany
Sponsor: Freya Biosciences ApS
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.